Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Family with sequence similarity 133 member F, pseudogene (FAM133FP) is a genomic locus annotated as a pseudogene; it is a noncoding, evolutionary remnant of a gene that has lost protein-coding capacity through mutation or deletion[5][1]. Pseudogenes may, in some cases, have regulatory biological functions as noncoding RNAs, including serving as microRNA decoys or sources of small interfering RNAs (siRNAs)[2][3][6][4]. However, there is no specific evidence that FAM133FP has a characterized biological or disease-related function, nor is it a canonical receptor, enzyme, or therapeutic target. It should not be considered a drug target or biomarker, and its inclusion in target lists is likely due to generic pseudogene annotation rather than specific functional relevance[5][1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Family with sequence similarity 133 member F, pseudogene (FAM133FP).